JoséMaríaRojo, Pilar Portolés
116
7. Lees-‐Miller, S. P. PIKK-‐ing a newpartner: Anewrole for PKB in theDNAdamage response.
CancerCell
13
, 379-‐380(2008).
8. van der Burg, M.; Ijspeert, H.; Verkaik, N. S.; Turul, T.; Wiegant, W. W.; Morotomi-‐Yano, K.;
Mari, P.-‐O.; & al. A
DNA-‐PKcs
mutation in a radiosensitive T
-‐
B
-‐
SCID patient inhibits
Artemis activationandnonhomologous end-‐joining.
J Clin Invest
119
, 91-‐98(2009).
9. Knight, Z. A.; Gonzalez, B.; Feldman, M. E.; Zunder, E. R.; Goldenberg, D. D.; Williams, O.;
Loewith, R.; & al. A pharmacological map of the PI3-‐K family defines a role for p110
α
in
Insulinsignaling.
Cell
125
, 733-‐747(2007).
10. Kurig, B.; Shymanets, A.; Bohnacker, T.; Prajwal; Brock, C.; Ahmadian, M. R.; Schaefer, M.; &
al. Ras is an indispensable coregulator of the class I
B
phosphoinositide 3-‐kinase
p87/p110
γ
.
ProcNatl AcadSci USA
106
, 20312-‐20317(2009).
11. Huang, C.-‐H.; Mandelker, D.; Schmidt-‐Kittler, O.; Samuels, Y.; Velculescu, V. E.; Kinzler, K.
W.; Vogelstein, B.; & al. The structure of a human p110
α
/p85
α
complex elucidates the
effectsof oncogenicPI3K
α
mutations.
Science
318
, 1744-‐1748(2007).
12. Backer, J. M. The regulation of Class IA PI 3-‐Kinases by inter-‐subunit interactions. In
Rommel, C.; Vanhaesebroeck, B.; & Vogt, P. K., Editors. In
Phosphoinositide 3-‐kinase in
HealthandDisease
; SpringerBerlinHeidelberg, 2010; p. 87-‐114.
13. Fruman, D. A. Regulatory Subunits of Class IA PI3K. In Rommel, C.; Vanhaesebroeck, B.; &
Vogt, P. K., Editors. In
Phosphoinositide 3-‐kinase in Health and Disease
; Springer Berlin
Heidelberg, 2010; p. 225-‐244.
14. Acosta, Y.; Zafra, M.; Ojeda, G.; Bernardone, I.; Dianzani, U.; Portolés, P.; & Rojo, J. Biased
binding of class IA phosphatidyl inositol 3-‐kinase subunits to inducible costimulator
(CD278).
CellMol LifeSci
68
, 3065-‐3079(2011).
15. Delgado, P.; Cubelos, B.; Calleja, E.;Martinez-‐Martin, N.; Cipres, A.;Merida, I.; Bellas, C.;&al.
Essential function for the GTPase TC21 in homeostatic antigen receptor signaling.
Nat
Immunol
10
, 880-‐888(2009).
16. Rodriguez-‐Viciana, P.; Sabatier, C.; & McCormick, F. Signaling specificity by Ras family
GTPases is determined by the full spectrum of effectors they regulate.
Mol Cell Biol
24
,
4943-‐4954(2004).
17. Parry, R. V.; Riley, J. L.; &Ward, S. G. Signalling to suit function: tailoring phosphoinositide
3-‐kinaseduringT-‐cell activation.
Trends Immunol
28
, 161-‐168(2007).
18. Huang, Y. H.; & Sauer, K. Lipid signaling in T-‐cell development and function.
C ld Spring
HarbPerspectBiol
2
, a002428(2010).
19.Ward, S. G.; &Blunt, M. D. Pharmacological targeting of phosphoinositide lipid kinases and
phosphatases in the immune system: Success, disappointment and new opportunities.
Front Immunol
3
, 226(2012).
20. Fos, C.; Salles, A.; Lang, V.; Carrette, F.; Audebert, S.; Pastor, S.; Ghiotto, M.; & al. ICOS
ligation recruits the p50
α
PI3K regulatory subunit to the Immunological Synapse.
J
Immunol
181
, 1969-‐1977(2008).
21. Ward, S. G.; & Cantrell, D. A. Phosphoinositide 3-‐kinases in T lymphocyte activation.
Curr
Opinion Immunol
13
, 332-‐338(2001).
22. So, L.; & Fruman, D. A. PI3K signalling in B-‐ and T-‐lymphocytes: new developments and
therapeuticadvances.
BiochemJ
442
, 465-‐481(2012).
23. Guillermet-‐Guibert, J.; Bjorklof, K.; Salpekar, A.; Gonella, C.; Ramadani, F.; Bilancio, A.;Meek,
S.; &al. Thep110
β
isoformof phosphoinositide3-‐kinase signalsdownstreamof Gprotein-‐
coupled receptors and is functionally redundant with p110
γ
.
Proc Natl Acad Sci USA
105
,
8292-‐8297(2008).
24. Alcazar, I.; Marques, M.; Kumar, A.; Hirsch, E.; Wymann, M.; Carrera, A. C.; & Barber, D. F.
Phosphoinositide 3 kinase
γ
participates in T cell receptor induced T cell activation.
J Exp
Med
204
, 2977-‐2987(2007).
25. Nombela-‐Arrieta, C.; Lacalle, R. A.; Montoya, M. C.; Kunisaki, Y.; Megías, D.; Marqués, M.;
Carrera, A. C.; & al. Differential requirements for DOCK2 and Phosphoinositide-‐3-‐Kinase
γ
duringTandB lymphocytehoming.
Immunity
21
, 429-‐441(2004).
26. Reif, K.; Okkenhaug, K.; Sasaki, T.; Penninger, J. M.; Vanhaesebroeck, B.; & Cyster, J. G.
Cutting edge: Differential roles for Phosphoinositide 3-‐Kinases, p110
γ
and p110
δ
, in
lymphocytechemotaxis andhoming.
J Immunol
173
, 2236-‐2240(2004).
27. Manning, B. D.; & Cantley, L. C. AKT/PKB signaling: Navigating downstream.
Cell
129
,
1261-‐1274(2007).
